Frederick M. Hudson, Director at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 920 shares at $24.44 ($22K) on 2020-07-13, disclosed to the SEC on 2020-07-15.
Scheduled sale ($22k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SUPN | SELL | 2024-11-12 | $633K | — | Filing → |
| SUPN | SELL | 2023-11-17 | $408K | — | Filing → |
| SUPN | BUY | 2012-05-07 | $25K | — | Filing → |